Page last updated: 2024-08-26

phorbolol myristate acetate and Cancer of Pituitary

phorbolol myristate acetate has been researched along with Cancer of Pituitary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdel-Fattah, R; Agi, CU; Amos, S; Fang, Z; Hussaini, IM; Laws, ER; Leung, GK; Lopes, MB; Redpath, GT; Trotter, C; Xiao, A; Zhao, Y	1

Other Studies

1 other study(ies) available for phorbolol myristate acetate and Cancer of Pituitary

Article	Year
Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. The American journal of pathology, 2007, Volume: 170, Issue:1 Topics: Adenoma; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Pituitary Neoplasms; Protein Kinase C; Pyrones; RNA, Small Interfering; Tetradecanoylphorbol Acetate	2007

Article

Year

Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line.

The American journal of pathology, 2007, Volume: 170, Issue:1

Topics: Adenoma; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Pituitary Neoplasms; Protein Kinase C; Pyrones; RNA, Small Interfering; Tetradecanoylphorbol Acetate

2007